ESIH.L vs. BTEE.L
ESIH.L (iShares MSCI Europe Health Care Sector UCITS ETF) and BTEE.L (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) are both Health & Biotech Equities funds from iShares - ESIH.L tracks the MSCI World/Health Care NR USD while BTEE.L tracks the NASDAQ Biotechnology TR USD. Both are passively managed. Over the past 5 years, ESIH.L returned 5.89%/yr vs 5.84%/yr for BTEE.L. A 0.50 correlation means they provide meaningful diversification when combined. ESIH.L charges 0.18%/yr vs 0.35%/yr for BTEE.L.
Performance
ESIH.L vs. BTEE.L - Performance Comparison
Loading charts...
Different Trading Currencies
ESIH.L is traded in GBP, while BTEE.L is traded in USD. To make them comparable, the BTEE.L values have been converted to GBP using the latest available exchange rates.
Returns By Period
In the year-to-date period, ESIH.L achieves a -2.72% return, which is significantly lower than BTEE.L's 5.01% return.
ESIH.L
- 1D
- 3.06%
- 1M
- 1.79%
- YTD
- -2.72%
- 6M
- -1.50%
- 1Y
- 8.89%
- 3Y*
- 2.83%
- 5Y*
- 5.89%
- 10Y*
- —
BTEE.L
- 1D
- 3.30%
- 1M
- 2.09%
- YTD
- 5.01%
- 6M
- 2.46%
- 1Y
- 42.82%
- 3Y*
- 10.28%
- 5Y*
- 5.84%
- 10Y*
- —
ESIH.L vs. BTEE.L - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
ESIH.L iShares MSCI Europe Health Care Sector UCITS ETF | -2.72% | 12.76% | -0.46% | 5.44% | 1.56% | 17.09% | 0.82% |
BTEE.L iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) | 5.01% | 23.36% | 0.03% | 0.55% | -1.41% | 0.37% | 7.34% |
Correlation
The correlation between ESIH.L and BTEE.L is 0.57, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.57 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.50 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.51 |
Correlation (All Time) Calculated using the full available price history since Nov 24, 2020 | 0.50 |
The correlation between ESIH.L and BTEE.L has been stable across timeframes, ranging from 0.50 to 0.57 - a consistent structural relationship.
ESIH.L vs. BTEE.L - Sectors Allocation Comparison
Sectors
ESIH.L
BTEE.L
Healthcare
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
-
Industrials
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
ESIH.L
BTEE.L
Basic Materials
ESIH.L
-
BTEE.L
-
Communication Services
ESIH.L
-
BTEE.L
-
Consumer Cyclical
ESIH.L
-
BTEE.L
-
Consumer Defensive
ESIH.L
-
BTEE.L
-
Energy
ESIH.L
-
BTEE.L
-
Financial Services
ESIH.L
-
BTEE.L
-
Industrials
ESIH.L
-
BTEE.L
-
Real Estate
ESIH.L
-
BTEE.L
-
Technology
ESIH.L
-
BTEE.L
-
Utilities
ESIH.L
-
BTEE.L
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ESIH.L vs. BTEE.L — Risk / Return Rank
ESIH.L
BTEE.L
ESIH.L vs. BTEE.L - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares MSCI Europe Health Care Sector UCITS ETF (ESIH.L) and iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) (BTEE.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| ESIH.L | BTEE.L | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.65 | ||
| Sortino ratioReturn per unit of downside risk | -2.11 | ||
| Omega ratioGain probability vs. loss probability | 1.10 | 1.36 | -0.26 |
| Calmar ratioReturn relative to maximum drawdown | 0.64 | 6.09 | -5.45 |
| Martin ratioReturn relative to average drawdown | 1.54 | 17.42 | -15.88 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| ESIH.L | BTEE.L | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.53 | 2.17 | -1.65 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.38 | 0.28 | +0.10 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.39 | 0.32 | +0.07 |
Drawdowns
ESIH.L vs. BTEE.L - Drawdown Comparison
The maximum ESIH.L drawdown since its inception was -24.44%, smaller than the maximum BTEE.L drawdown of -30.88%. Use the drawdown chart below to compare losses from any high point for ESIH.L and BTEE.L.
Loading charts...
Drawdown Indicators
| ESIH.L | BTEE.L | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -24.44% | -30.88% | +6.44% |
Max Drawdown (1Y)Largest decline over 1 year | -13.81% | -7.00% | -6.81% |
Max Drawdown (3Y)Largest decline over 3 years | -24.44% | -26.47% | +2.03% |
Max Drawdown (5Y)Largest decline over 5 years | -24.44% | -30.88% | +6.44% |
Current DrawdownCurrent decline from peak | -10.94% | -1.76% | -9.18% |
Average DrawdownAverage peak-to-trough decline | -6.76% | -10.12% | +3.36% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.77% | 2.45% | +3.32% |
Volatility
ESIH.L vs. BTEE.L - Volatility Comparison
The current volatility for iShares MSCI Europe Health Care Sector UCITS ETF (ESIH.L) is 5.50%, while iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) (BTEE.L) has a volatility of 7.01%. This indicates that ESIH.L experiences smaller price fluctuations and is considered to be less risky than BTEE.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ESIH.L | BTEE.L | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.50% | 7.01% | -1.51% |
Volatility (6M)Calculated over the trailing 6-month period | 12.21% | 15.10% | -2.89% |
Volatility (1Y)Calculated over the trailing 1-year period | 16.83% | 19.60% | -2.77% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 15.50% | 20.72% | -5.22% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 15.36% | 22.42% | -7.06% |
ESIH.L vs. BTEE.L - Expense Ratio Comparison
ESIH.L has a 0.18% expense ratio, which is lower than BTEE.L's 0.35% expense ratio.
Dividends
ESIH.L vs. BTEE.L - Dividend Comparison
ESIH.L has not paid dividends to shareholders, while BTEE.L's dividend yield for the trailing twelve months is around 0.36%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
BTEE.L iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) | 0.36% | 0.37% | 0.46% | 0.39% | 0.44% | 0.25% | 0.17% | 0.14% | 0.07% |
ESIH.L iShares MSCI Europe Health Care Sector UCITS ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
ESIH.L and BTEE.L have a correlation of 0.57, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, ESIH.L is cheaper at 0.18% per year. The better choice depends on whether you care most about return, fees, risk, or income.
ESIH.L is cheaper with a 0.18% expense ratio, compared with 0.35% for BTEE.L.
ESIH.L tracks MSCI World/Health Care NR USD, while BTEE.L tracks NASDAQ Biotechnology TR USD. Their fees differ too: 0.18% for ESIH.L and 0.35% for BTEE.L.
Find the right allocation for ESIH.L and BTEE.L
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer